Life science and chemical instrumentation is used in research & development activities in industrial laboratories, biotechnology industry, pharmaceutical industries, and academic institutes. It is also used in testing the quality of food products, laboratory information management system, and monitor & control process in manufacturing plants. The chemical properties and composition is studies with the help of life science and chemical instrumentation. Thus, these instruments play significant role in scientific analysis of living organism in biotechnology and molecular biology.
Favorable government policies for pharmaceutical R&D in emerging nations and growing food safety concerns fuels the growth of the world life science and chemical instrumentation market. In addition, technological advancements in analytical devices supplements growth. However, high cost of instruments and presence of alternative technologies are factors restraining the growth of the market. On the other hand, growing proteomics market, increasing environmental safety concerns, and demand from applied markets are creating opportunities in the market.
The world life science and chemical instrumentation market is segmented based on technology, end users, and geography. The technology segment is further classified into chromatography, DNA sequencers & amplifiers, electrophoresis, lab automation, spectroscopy, microarray, flow cytometry, immunoassay, and other instruments. Other instruments include incubators, fume hoods, lab balances, and centrifuges. End users covered in the report are pharmaceutical, biopharmaceutical, & biotechnology companies, clinical research organizations, academic institutions, hospitals, clinics, & diagnostic laboratories, forensic science laboratories, food & agriculture industry, and environmental testing industry. The market is divided geographically into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
The prominent companies operating in the market are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton, Dickinson, & Company, Bruker Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., PerkinElmer Inc., Danaher Corporation, Shimadzu Corporation, and Waters Corporation. Some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market are partnerships, mergers & acquisitions, expansions, joint ventures, collaborations, and others.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Key Market Players:
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research